118 related articles for article (PubMed ID: 14959855)
1. Autoimmune thrombocytopenia in chronic myeloid leukemia treated with interferon-alpha: differential diagnosis and possible pathogenesis.
Herishanu Y; Trestman S; Kirgner I; Rachmani R; Naparstek E
Leuk Lymphoma; 2003 Dec; 44(12):2103-8. PubMed ID: 14959855
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune mediated thrombocytopenia associated with the use of interferon-alpha in chronic myeloid leukemia.
Zuffa E; Vianelli N; Martinelli G; Tazzari P; Cavo M; Tura S
Haematologica; 1996; 81(6):533-5. PubMed ID: 9009441
[TBL] [Abstract][Full Text] [Related]
3. Development of hyperthyroidism during long term interferon therapy in a patient with chronic myelogenous leukemia: case report.
Ozet A; Ozet G; Calişkaner Z; Kömürcü S; Oztürk B
Endocr J; 1997 Oct; 44(5):715-7. PubMed ID: 9466328
[TBL] [Abstract][Full Text] [Related]
4. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
[TBL] [Abstract][Full Text] [Related]
5. Severe autoimmune hepatitis in a chronic myeloid leukemia patient treated with interferon alpha and with complete genetic response.
Steegmann JL; Requena MJ; García-Buey ML; Granados E; Romero R; Fernández-Rañada JM; Moreno R
Am J Hematol; 1998 Sep; 59(1):95-7. PubMed ID: 9723586
[TBL] [Abstract][Full Text] [Related]
6. Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia.
Arimura K; Arima N; Ohtsubo H; Matsushita K; Kukita T; Ayukawa T; Kuroki T; Tei C
Acta Haematol; 2004; 112(4):217-8. PubMed ID: 15564735
[TBL] [Abstract][Full Text] [Related]
7. Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-alpha in 1st trimester: report of 3 cases and review of the literature.
Mubarak AA; Kakil IR; Awidi A; Al-Homsi U; Fawzi Z; Kelta M; Al-Hassan A
Am J Hematol; 2002 Feb; 69(2):115-8. PubMed ID: 11835347
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha induced autoimmune hepatitis in a patient with Philadelphia chromosome-positive chronic myeloid leukemia with cytogenetically normal T lymphocytes.
Ariad S; Song E; Cohen R; Bezwoda WR
Mol Biother; 1992 Sep; 4(3):139-42. PubMed ID: 1445668
[TBL] [Abstract][Full Text] [Related]
9. High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-alpha.
Steegmann JL; Requena MJ; Martín-Regueira P; De La Cámara R; Casado F; Salvanés FR; Fernández Rañada JM
Am J Hematol; 2003 Mar; 72(3):170-6. PubMed ID: 12605388
[TBL] [Abstract][Full Text] [Related]
10. Emergence of unusual cytogenetic abnormalities under interferon-alpha therapy in patients with chronic myelogenous leukemia.
Maloisel F; Uettwiller F; Laplace A; Lioure B; Herbrecht R; Mark M; Dufour P
Cancer Genet Cytogenet; 1999 Sep; 113(2):172-6. PubMed ID: 10484986
[TBL] [Abstract][Full Text] [Related]
11. [Interferon-alpha-associated polyarthritis. Possible induction of seropositive rheumatoid arthritis by interferon-alpha: two case reports and review of the literature].
Kötter I; Müller CA; Einsele H; Mohren M; Kanz L
Z Rheumatol; 1999 Aug; 58(4):185-95. PubMed ID: 10502017
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
[TBL] [Abstract][Full Text] [Related]
13. Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia.
Tannir NM; Talpaz M; Ghazal H; Proothi S; Kantarjian HM
Leuk Lymphoma; 2000 Nov; 39(5-6):647-50. PubMed ID: 11342349
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response.
Martinelli G; Montefusco V; Amabile M; Lemoli RM; Terragna C; Testoni N; Ottaviani E; Rosti G; de Vivo A; Rizzi S; Russo D; Bregoli M; Tura S
Leuk Lymphoma; 2000 Sep; 39(1-2):113-20. PubMed ID: 10975389
[TBL] [Abstract][Full Text] [Related]
15. Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia.
Manley R; Cochrane J; McDonald M; Rigby S; Moore A; Kirk A; Clarke S; Crossen PE; Morris CM; Patton WN
Leukemia; 1999 Jan; 13(1):126-9. PubMed ID: 10049047
[TBL] [Abstract][Full Text] [Related]
16. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
Cohen MH; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Jan; 11(1):12-9. PubMed ID: 15671523
[TBL] [Abstract][Full Text] [Related]
17. Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha.
Ohashi N; Yonemura K; Sugiura T; Isozaki T; Togawa A; Fujigaki Y; Yamamoto T; Hishida A
Am J Kidney Dis; 2003 Mar; 41(3):E10. PubMed ID: 12613003
[TBL] [Abstract][Full Text] [Related]
18. PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India.
Guru SA; Mir R; Bhat M; Najar I; Zuberi M; Sumi M; Masroor M; Gupta N; Saxena A
Tumour Biol; 2017 Oct; 39(10):1010428317713857. PubMed ID: 29019285
[TBL] [Abstract][Full Text] [Related]
19. [Autoimmune phenomena during interferon-alpha therapy for hematopoietic disorders].
Iguchi T; Nishimaki J; Kawakubo K; Shimamoto T; Iwase O; Suzuki A; Kuriyama Y; Ito Y; Tauchi T; Yaguchi M; Miyazawa K; Kimura Y; Ohyashiki K
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1911-6. PubMed ID: 14650958
[TBL] [Abstract][Full Text] [Related]
20. Severe cytopenias associated with the sequential use of busulphan and interferon-alpha in chronic myeloid leukaemia.
Shepherd PC; Richards S; Allan NC
Br J Haematol; 1994 Jan; 86(1):92-6. PubMed ID: 8011552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
